We hypothesized that the triglyceride–glucose (TyG)–alanine aminotransferase (ALT) index, which combines the TyG index with ALT, may enhance sensitivity and specificity in detecting the severity of nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.